Medical University of Vienna, Department of Ophthalmology and Optometry
Vienna, State of Vienna, 1090, Austria
Location status: Recruiting
NCT Number: NCT07452042
The aim of this clinical study is to evaluate a toric add-on intraocular lens (IOL) for the correction of high astigmatism in patients who have undergone keratoplasty and cataract surgery. As this patient group often suffers from significant preoperative residual astigmatism, there is a relevant clinical need for effective and safe refractive treatment options. The implantation of a toric add-on IOL in the ciliary sulcus is intended to significantly reduce postoperative astigmatism and improve visual rehabilitation.
The study is designed as a prospective, monocentric clinical trial with a limited number of cases, as this is a rare condition with limited availability of suitable patients. It is being conducted in accordance with Section 3 of the Austrian Medical Devices Act (MPG 2021) and is investigating a CE-marked add-on intraocular lens implant used within its intended purpose. The postoperative refractive cylinder serves as the primary endpoint, as it reflects the actual effectiveness of astigmatism correction. The rotational stability of the add-on IOL, which significantly influences refractive precision, is recorded as a secondary endpoint.
All study participants will be examined pre- and postoperatively in accordance with applicable medical standards. The results should contribute to the optimization of refractive care after keratoplasty and assess the clinical applicability of toric AddOn IOLs in this specific indication.
Interested in participating?
Request Info45 year–95 year
All sexes
Observational
Vienna, State of Vienna, 1090, Austria
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Implantation of a toric AddOn IOL in the ciliary sulcus of patients after cataract surgery and keratoplasty with a high postoperative refractive cylinder.
Time frame: 4-7 months
The primary endpoint is the proportion of eyes achieving a ≥50% reduction in refractive cylinder postoperatively at the last visit (4 - 7 months). The postoperative refractive cylinder will be assessed by subjective refraction using a Snellen chart at 6 m.
A one-sided exact binomial test (α = 0.05) will be used to determine if this proportion is greater than 70%. The 90% two-sided Clopper-Pearson confidence interval will also be reported.
Time frame: 4-7 months
The rotation of the IOLs over the first 4-7 postoperative months will be assessed with retroillumination photography (intraoperatively, 1 hour postoperatively, 1 week postoperatively, 1 month postoperatively, 6 months postoperatively). These images will be imported into the semi-automated evaluation software Rotix (labVIEW, National Instruments, Austin, Texas, USA). Two lines will be drawn to determine the IOL axis: one between two non-movable vessels serving as the reference axis, and a second one between the axis markings of the IOL. The Rotix software will then automatically calculate the axis difference between follow-up visits.
Time frame: 4-7 months
Assessment of IOL decentration will be performed under mydriatic conditions using the AS-OCT Casia 2 (Tomey Corporation, Nagoya, Japan) preoperatively, as well as at 1 week, 1 month and 6 months postoperatively. Decentration will be calculated using the cataract module with semi-automatic correction.
IOL decentration will be defined as the horizontal and vertical distance from the center of the lens to the corneal vertex.
Time frame: 4-7 months
Assessment of tiltwill be performed under mydriatic conditions using the AS-OCT Casia 2 (Tomey Corporation, Nagoya, Japan) preoperatively, as well as at 1 week, 1 month and 6 months postoperatively. Tilt will be calculated using the cataract module with semi-automatic correction. IOL tilt will be defined as the horizontal and vertical angle of the lens relative to the corneal vertex.
Time frame: 4-7 months
The aqueous depth (AQD) will be measured preoperatively and at 1 week and 6 months postoperatively using the AS-OCT Casia 2, all under maximum pupil dilation. Postoperative axial stability of the toric AddOn IOL will be calculated by subtracting the 1-week AQD from the 6-month AQD. Accordingly, a positive value will indicate a hyperopic shift and a negative value will indicate a myopic shift.
Medical University of Vienna
Other
Postoperative Outcomes of a Toric Add-On Intraocular Lens After Keratoplasty and Cataract Surgery
Acronym: AddOn
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07158177
Cataract, Cataract and IOL Surgery
Paris, Île-de-France Region, France
View Trial DetailsNCT07294716
Astigmatism, Cataract
Linz, Austria
View Trial DetailsNCT07325162
Cataract, Cataract and IOL Surgery
Hilton Head Island, South Carolina, United States
View Trial DetailsNCT07325188
Cataract, Cataract and IOL Surgery
Gainesville, Georgia, United States
View Trial Details